Mayo Clinic recently announced separate generative artificial intelligence collaborations with Microsoft Research and ...

Chiefs Hall of Honor member Art Still is a proud foot soldier in the Amyloidosis Army, a nonprofit he started hoping to ...

LATE-NC diagnostic criteria improve differentiation from Alzheimer's, addressing challenges in memory-loss syndromes and guiding therapeutic interventions.

Japanese pharmaceutical company Eisai Co and U.S. firm Biogen Inc said Monday that a jointly developed Alzheimer's drug has been approved for continuous use for people with early stages of the disease ...

The AL Amyloidosis market is expected to experience substantial growth, driven by the rising demand for effective therapies, advances in genetic research, and ongoing clinical trials focused on ...

AL Amyloidosis is a rare and serious disease, with an estimated 8,600 incident cases in the 7MM countries (United States, EU5—Germany, France, Italy, Spain, and the United Kingdom—and Japan ...

Diseases spread through saliva include mononucleosis, strep throat, rotavirus, and even tooth decay. Many diseases can be spread through saliva alone, including viral and bacterial infections. Our ...

Alzheimer’s disease is characterized by the buildup of harmful proteins in the brain, specifically amyloid plaques and tau tangles, along with increased brain inflammation and neuron damage.

Local amyloid deposition occurs in the brain in Alzheimer's disease and in the pancreas in maturity-onset diabetes, but a direct role in the pathogenesis of these diseases remains unproven.

Lasunadya Ghrita (LG), an Ayurvedic remedy, shows promise in breaking down toxic amyloid proteins linked to Alzheimer's disease LG outperforms synthetic peptides in disaggregating amyloid-prone ...

Most treatments being pursued today to protect against Alzheimer’s disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and ...